{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:16:27Z","timestamp":1790396187941,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1124\/mol.108.054312","type":"journal-article","created":{"date-parts":[[2009,3,17]],"date-time":"2009-03-17T01:08:58Z","timestamp":1237252138000},"page":"1317-1324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Met909 Plays a Key Role in the Activation of the Progesterone Receptor and Also in the High Potency of 13-Ethyl Progestins"],"prefix":"10.1016","volume":"75","author":[{"given":"Isabelle","family":"Petit-Topin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Turque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Fagart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Ulmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Gainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Edith","family":"Rafestin-Oblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.108.054312_bib1","doi-asserted-by":"crossref","unstructured":"Allan GF, Leng X, Tsai SY, Weigel NL, Edwards DP, Tsai MJ, and O\u2019Malley BW (1992) Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem 267: 19513-195220.","DOI":"10.1016\/S0021-9258(18)41805-4"},{"key":"10.1124\/mol.108.054312_bib2","doi-asserted-by":"crossref","unstructured":"Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM, et al. (2002) Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110: 93-105.","DOI":"10.1016\/S0092-8674(02)00817-6"},{"key":"10.1124\/mol.108.054312_bib3","doi-asserted-by":"crossref","unstructured":"Bledsoe RK, Madauss KP, Holt JA, Apolito CJ, Lambert MH, Pearce KH, Stanley TB, Stewart EL, Trump RP, Willson TM, et al. (2005) A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. J Biol Chem 280: 31283-31293.","DOI":"10.1074\/jbc.M504098200"},{"key":"10.1124\/mol.108.054312_bib4","doi-asserted-by":"crossref","unstructured":"Br\u00fcnger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, et al. (1998) Crystallography and NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54: 905-921.","DOI":"10.1107\/S0907444998003254"},{"key":"10.1124\/mol.108.054312_bib5","doi-asserted-by":"crossref","unstructured":"de Wet JR, Wood KV, DeLuca M, Helinski DR, and Subramani S (1987) Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 7: 725-737.","DOI":"10.1128\/MCB.7.2.725"},{"key":"10.1124\/mol.108.054312_bib6","doi-asserted-by":"crossref","unstructured":"Fagart J, Wurtz JM, Souque A, Hellal-Levy C, Moras D, and Rafestin-Oblin ME (1998) Antagonism in the human mineralocorticoid receptor. EMBO J 17: 3317-3325.","DOI":"10.1093\/emboj\/17.12.3317"},{"key":"10.1124\/mol.108.054312_bib7","doi-asserted-by":"crossref","unstructured":"Fagart J, Huyet J, Pinon GM, Rochel M, Mayer C, and Rafestin-Oblin ME (2005) Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nat Struct Mol Biol 12: 554-555.","DOI":"10.1038\/nsmb939"},{"key":"10.1124\/mol.108.054312_bib8","doi-asserted-by":"crossref","unstructured":"Georgiakaki M, Chabbert-Buffet N, Dasen B, Meduri G, Wenk S, Rajhi L, Amazit L, Chauchereau A, Burger CW, Blok LJ, et al. (2006) Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription. Mol Endocrinol 20: 2122-2140.","DOI":"10.1210\/me.2005-0149"},{"key":"10.1124\/mol.108.054312_bib9","doi-asserted-by":"crossref","unstructured":"Hellal-Levy C, Couette B, Fagart J, Souque A, Gomez-Sanchez C, and Rafestin-Oblin ME (1999) Specific hydroxylations determine selective corticosteroid recognition by human glucocorticoid and mineralocorticoid receptors. FEBS Lett 464: 9-13.","DOI":"10.1016\/S0014-5793(99)01667-1"},{"key":"10.1124\/mol.108.054312_bib10","doi-asserted-by":"crossref","unstructured":"Hellal-Levy C, Fagart J, Souque A, Wurtz JM, Moras D, and Rafestin-Oblin ME (2000) Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor. Mol Endocrinol 14: 1210-1221.","DOI":"10.1210\/mend.14.8.0502"},{"key":"10.1124\/mol.108.054312_bib11","doi-asserted-by":"crossref","unstructured":"Herbomel P, Bourachot B, and Yaniv M (1984) Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 39: 653-662.","DOI":"10.1016\/0092-8674(84)90472-0"},{"key":"10.1124\/mol.108.054312_bib12","doi-asserted-by":"crossref","unstructured":"Kabsch W (1993) Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J Appl Crystallogr 26: 795-800.","DOI":"10.1107\/S0021889893005588"},{"key":"10.1124\/mol.108.054312_bib13","doi-asserted-by":"crossref","unstructured":"Laskowski RA, MacArthur MW, Moss DS, and Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26: 283-291.","DOI":"10.1107\/S0021889892009944"},{"key":"10.1124\/mol.108.054312_bib14","doi-asserted-by":"crossref","unstructured":"Lind U, Greenidge P, Gillner M, Koehler KF, Wright A, and Carlstedt-Duke J (2000) Functional probing of the human glucocorticoid receptor steroid-interacting surface by site-directed mutagenesis. Gln-642 plays an important role in steroid recognition and binding. J Biol Chem 275: 19041-19049.","DOI":"10.1074\/jbc.M000228200"},{"key":"10.1124\/mol.108.054312_bib15","doi-asserted-by":"crossref","unstructured":"Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, Weigel NL, et al. (2006) The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev 58: 782-797.","DOI":"10.1124\/pr.58.4.9"},{"key":"10.1124\/mol.108.054312_bib16","doi-asserted-by":"crossref","unstructured":"Madauss KP, Deng SJ, Austin RJ, Lambert MH, McLay I, Pritchard J, Short SA, Stewart EL, Uings IJ, and Williams SP (2004) Progesterone receptor ligand binding pocket flexibility: crystal structures of the norethindrone and mometasone furoate complexes. J Med Chem 47: 3381-3387.","DOI":"10.1021\/jm030640n"},{"key":"10.1124\/mol.108.054312_bib17","doi-asserted-by":"crossref","unstructured":"Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Sch\u00fctz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, et al. (1995) The nuclear receptor superfamily: the second decade. Cell 83: 835-839.","DOI":"10.1016\/0092-8674(95)90199-X"},{"key":"10.1124\/mol.108.054312_bib18","doi-asserted-by":"crossref","unstructured":"Matias PM, Donner P, Coelho R, Thomaz M, Peixoto C, Macedo S, Otto N, Joschko S, Scholz P, Wegg A, et al. (2000) Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J Biol Chem 275: 26164-26171.","DOI":"10.1074\/jbc.M004571200"},{"key":"10.1124\/mol.108.054312_bib19","doi-asserted-by":"crossref","unstructured":"Nagy L and Schwabe JW (2004) Mechanism of the nuclear receptor molecular switch. Trends Biochem Sci 29: 317-324.","DOI":"10.1016\/j.tibs.2004.04.006"},{"key":"10.1124\/mol.108.054312_bib20","doi-asserted-by":"crossref","unstructured":"Pereira de J\u00e9sus-Tran K, C\u00f4t\u00e9 PL, Cantin L, Blanchet J, Labrie F, and Breton R (2006) Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity. Protein Sci 15: 987-999.","DOI":"10.1110\/ps.051905906"},{"key":"10.1124\/mol.108.054312_bib21","doi-asserted-by":"crossref","unstructured":"Poujol N, Wurtz JM, Tahiri B, Lumbroso S, Nicolas JC, Moras D, and Sultan C (2000) Specific recognition of androgens by their nuclear receptor. A structure-function study. J Biol Chem 275: 24022-24032.","DOI":"10.1074\/jbc.M001999200"},{"key":"10.1124\/mol.108.054312_bib22","doi-asserted-by":"crossref","unstructured":"Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, and Thijssen JH (2003) Classification and pharmacology of progestins. Maturitas 46 ( Suppl 1 ): S7-S16.","DOI":"10.1016\/j.maturitas.2003.09.014"},{"key":"10.1124\/mol.108.054312_bib23","doi-asserted-by":"crossref","unstructured":"Sitruk-Ware R (2004) Pharmacological profile of progestins. Maturitas 47: 277-283.","DOI":"10.1016\/j.maturitas.2004.01.001"},{"key":"10.1124\/mol.108.054312_bib24","doi-asserted-by":"crossref","unstructured":"Sitruk-Ware R (2007) The levonorgestrel intrauterine system for use in peri- and postmenopausal women. Contraception 75 (6 Suppl): S155-S160.","DOI":"10.1016\/j.contraception.2007.01.010"},{"key":"10.1124\/mol.108.054312_bib25","doi-asserted-by":"crossref","unstructured":"Souque A, Fagart J, Couette B, Davioud E, Sobrio F, Marquet A, and Rafestin-Oblin ME (1995) The mineralocorticoid activity of progesterone derivatives depends on the nature of the C18 substituent. Endocrinology 136: 5651-5658.","DOI":"10.1210\/endo.136.12.7588320"},{"key":"10.1124\/mol.108.054312_bib26","doi-asserted-by":"crossref","unstructured":"Stanczyk FZ (2003) All progestins are not created equal. Steroids 68: 879-890.","DOI":"10.1016\/j.steroids.2003.08.003"},{"key":"10.1124\/mol.108.054312_bib27","doi-asserted-by":"crossref","unstructured":"Storoni LC, McCoy AJ, and Read RJ (2004) Likelihood-enhanced fast rotation functions. Acta Crystallogr D Biol Crystallogr 60: 432-438.","DOI":"10.1107\/S0907444903028956"},{"key":"10.1124\/mol.108.054312_bib28","doi-asserted-by":"crossref","unstructured":"Th\u00e9not S, Henriquet C, Rochefort H, and Cavaill\u00e8s V (1997) Differential interaction of nuclear receptors with the putative transcriptional coactivator hTIF1. J Biol Chem 272: 12062-12068.","DOI":"10.1074\/jbc.272.18.12062"},{"key":"10.1124\/mol.108.054312_bib29","doi-asserted-by":"crossref","unstructured":"Tsai MJ and O\u2019Malley BW (1994) Molecular mechanisms of action of steroid\/thyroid receptor superfamily members. Ann Rev Biochem 63: 451-486.","DOI":"10.1146\/annurev.bi.63.070194.002315"},{"key":"10.1124\/mol.108.054312_bib30","doi-asserted-by":"crossref","unstructured":"Tuba Z, Bardin CW, Dancsi A, Francsics-Czinege E, Moln\u00e1r C, Cs\u00f6rgei J, Falkay G, Koide SS, Kumar N, Sundaram K, et al. (2000) Synthesis and biological activity of a new progestogen, 16-methylene-17alpha-hydroxy-18-methyl-19-norpregn-4-ene-3, 20-dione acetate. Steroids 65: 266-274.","DOI":"10.1016\/S0039-128X(99)00109-9"},{"key":"10.1124\/mol.108.054312_bib31","doi-asserted-by":"crossref","unstructured":"Williams SP and Sigler PB (1998). Atomic structure of progesterone complexed with its receptor. Nature 393: 392-396.","DOI":"10.1038\/30775"},{"key":"10.1124\/mol.108.054312_bib32","doi-asserted-by":"crossref","unstructured":"Zhang Z, Olland AM, Zhu Y, Cohen J, Berrodin T, Chippari S, Appavu C, Li S, Wilhem J, Chopra R, et al. (2005) Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget. J Biol Chem 280: 28468-28475.","DOI":"10.1074\/jbc.M504144200"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24019497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24019497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.108.054312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:35:14Z","timestamp":1739957714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24019497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0026895X24019497"],"URL":"https:\/\/doi.org\/10.1124\/mol.108.054312","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Met909 Plays a Key Role in the Activation of the Progesterone Receptor and Also in the High Potency of 13-Ethyl Progestins","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.108.054312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}